M350-0921 Screening compound: (2E)-N-(4-{[5-(4-methoxyphenyl)-1,3,4-oxadiazol-2-yl]methoxy}phenyl)-3-(thiophen-2-yl)prop-2-enamide

M350-0921 Screening compound: (2E)-N-(4-{[5-(4-methoxyphenyl)-1,3,4-oxadiazol-2-yl]methoxy}phenyl)-3-(thiophen-2-yl)prop-2-enamide
M350-0921 Screening compound: (2E)-N-(4-{[5-(4-methoxyphenyl)-1,3,4-oxadiazol-2-yl]methoxy}phenyl)-3-(thiophen-2-yl)prop-2-enamide alternative view

Chemical Structure Depiction of ChemDiv screening compound M350-0921
(2E)-N-(4-{[5-(4-methoxyphenyl)-1,3,4-oxadiazol-2-yl]methoxy}phenyl)-3-(thiophen-2-yl)prop-2-enamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

M350-0921

Molecular Formula

C23H19N3O4S (C23 H19 N3 O4 S)

Compound Name

(2E)-N-(4-{[5-(4-methoxyphenyl)-1,3,4-oxadiazol-2-yl]methoxy}phenyl)-3-(thiophen-2-yl)prop-2-enamide

IUPAC name

(2E)-N-(4-{[5-(4-methoxyphenyl)-134-oxadiazol-2-yl]methoxy}phenyl)-3-(thiophen-2-yl)prop-2-enamide

SMILES

COc(cc1)ccc1-c1nnc(COc(cc2)ccc2NC(/C=C/c2cccs2)=O)o1

InChI

InChI=1S/C23H19N3O4S/c1-28-18-8-4-16(5-9-18)23-26-25-22(30-23)15-29-19-10-6-17(7-11-19)24-21(27)13-12-20-3-2-14-31-20/h2-14H,15H2,1H3,(H,24,27)

InChI Key

GOGPXXPOBUGHNE-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27538229

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

433.49

Hydrogen Bond Acceptors Count

7.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

9.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

4.107

Distribution Coefficient, logD

4.107

Water Solubility, LogSw

-4.20

Polar Surface Area

69.087

Acid Dissociation Constant (pKa)

12.17

Base Dissociation Constant (pKb)

3.67

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

8.70

M350-0921 in Drug Discovery

Included in Screening Libraries

Antimitotic Tubulin Library (17355 compounds)

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

Covalent Inhibitors Library (7986 compounds)

?ysteine Targeted Covalent Library (39471 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
Structure:
  • Cyclic compounds
  • 3D
  • Fragments

References: we are preparing a list of scientific research reports with M350-0921 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound M350-0921?
Check Price and Availability of M350-0921, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of M350-0921 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for M350-0921
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for M350-0921
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of M350-0921 available by request